Founded in 2017 by genomics students, Sano Genetics is based in Cambridge, UK, with its registered office in London. The company specializes in designing trial-enabling pre-screening protocols and supporting precision medicine research.
Subscribe to see Sano Genetics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sano Genetics is a biotech company headquartered in United Kingdom, founded in 2017. Its most recent funding round, ch-sh01:MzUwNDk1NzY3OWFkaXF6a2N4, raised $3.4M in February 2026.
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| ch-sh01:MzUwNDk1NzY3OWFkaXF6a2N4 | $3.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Sano Genetics's closest competitors — see the full list of competitors and alternatives →
Strata Oncology, Inc. is a precision medicine company headquartered in Ann Arbor, Michigan. The company provides advanced genomic profiling and clinical trial matching services to expand treatment options for cancer patients.
Precision for Medicine is a global clinical research organization (CRO) that utilizes advanced biomarker-driven technologies to maximize insights into patient biology and support clinical trials. The company is headquartered in Bethesda, Maryland.
Signios Bio is a US-based genomics and multiomics contract research laboratory offering next-generation sequencing, spatial transcriptomics, single-cell analysis, and bioinformatics services.
Biotx.ai applies large-scale Mendelian randomization and causal AI to human genetics data to map causal relationships between genes and biological outcomes. The company generates datasets and AI models that assist researchers and organizations in discovering novel drug targets and improving clinical trial design across various therapeutic areas.
CellCarta operates as a global contract research organization (CRO) providing specialized laboratory testing and biomarker services to support drug development and precision medicine. The company offers a wide range of services including immunology, proteomics, genomics, histopathology, and companion diagnostic development for pharmaceutical and biotechnology clients.
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Sano Genetics? Suggest a correction · Work at Sano Genetics? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.